Click and discover

George S. Vassiliou () and Shankar Balasubramanian ()
Additional contact information
George S. Vassiliou: Wellcome Trust Sanger Institute
Shankar Balasubramanian: University of Cambridge

Nature, 2017, vol. 548, issue 7666, 162-164

Abstract: Details of the activity of promising anticancer drugs known as BET inhibitors remain elusive. An approach called click chemistry enables in-depth analysis of how these drugs modulate the function of a crucial target protein, BRD4.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/548162a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:548:y:2017:i:7666:d:10.1038_548162a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/548162a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().